谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 139 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Efficacy and Safety of Lorlatinib in Patients with ALK- and ROS1-rearranged Metastatic Non-Small Cell Lung Cancer Treated Within the Compassionate Use Program in Spain
Antonio Calles, Mirian Alonso,Paloma Martín-Martorell, Ana Gómez,Javier de Castro, Maite Martínez-Aguillo,Anna Estival,Joaquin Mosquera, Natividad Martínez-Banaclocha,Margarita Majem,Roxana Reyes, Eider Azkona, Ana Laura Ortega, Santiago Aguin, Ana Santos, Andrés Aguilar, Marc Cucurull,Ana Blasco,Virginia Calvo,Dolores Isla,Ernest Nadal, Carlos Aguado,Elia Sais, Oscar Juan-Vidal, MPilar Diz-Taín,Álvaro Taus, Noemí Villanueva, Cristina Bayona, Margarita Amenedo,Xabier Mielgo, Esperanza Arriola, Javier Baena, Spanish Lung Cancer Group
Cancer treatment and research communications (2025): 100905-100905
引用0浏览0WOS引用
0
0
Non-bacterial Thrombotic Endocarditis in ROS1-rearranged Lung Cancer: a Report of Two Cases
Jordi Recuero-Borau,Laura Masfarre,Nil Navarro,Pedro Rocha,Alvaro Taus,Edurne Arriola
Translational Lung Cancer Researchno. 1 (2024): 179-185
引用1浏览0WOS引用
1
0
P2.11A.08 Molecular and Immunological Features Associated with Long-Term Benefit in Metastatic NSCLC Patients Undergoing Immune Checkpoint Blockade
P. Rocha, R. Bach,L. Masfarre, S. Hernandez,N. Navarro-Gorro, A. Rossell,X. Villanueva,M. Giner,I. Sanchez, M. Galindo,R. del Rey-Vergara, A. Inanez, B. Sanchez-Espiridion, W. Lu, A. Acedo-Terrades, P. Berenguer-Molins, A. Sanchez-Font, R. Chalela,V. Curull,A. Taus,M. Hardy-Werbin,M. Sausen,A. Georgiadis, J. White, J. B. Jackson,L. Moliner,S. Clave,B. Bellosillo,A. Rovira,I. Wistuba,L. M. Solis Soto, J. Perera-Bel,E. Arriola
JOURNAL OF THORACIC ONCOLOGYno. 10 (2024): S255-S255
引用0浏览0WOS引用
0
0
加载更多
作者统计

#Papers: 139

#Citation: 1290

H-Index: 22

G-Index: 34

Sociability: 7

Diversity: 3

Activity: 27

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn